UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                                  March 1, 2005
                                (Date of report)

                    CARACO PHARMACEUTICAL LABORATORIES, LTD.
             (Exact name of registrant as specified in its charter)

          Michigan                      0-24676                  38-2505723
(State or other jurisdiction    (Commission file number)      (I.R.S. employer
      of incorporation)                                      identification no.)

                1150 Elijah McCoy Drive, Detroit, Michigan 48202
                    (Address of principal executive offices)

                                 (313) 871-8400
              (Registrant's telephone number, including area code)

                                 Not Applicable
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      140.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))




Item 2.02. Results of Operations and Financial Condition and Item 7.01.
Regulation FD Disclosure

      On March 1, 2005, registrant announced its results of operations for the
year ended December 31, 2004, as set forth in the press release included as
Exhibit 99.1 hereto, which is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits

c)    Exhibits.

      Exhibit No.    Description
      -----------    -----------

      99.1           Press Release of Caraco Pharmaceutical Laboratories, Ltd.,
                     dated March 1, 2005 announcing 2004 year-end results of
                     operations.

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, registrant
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.

                    CARACO PHARMACEUTICAL LABORATORIES, LTD.


         Date:  March 1, 2005             By: /s/ Jitendra N. Doshi
                                              ----------------------------------
                                              Jitendra N. Doshi
                                              Chief Executive Officer




                                  Exhibit Index

99.1        Press Release of Caraco Pharmaceutical Laboratories, Ltd., dated
            March 1, 2005 announcing 2004 year-end results of operations.


                                       2